ALEXANDRA THURSTON: Open Payments
NPI 1548987977 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,294 in 158 payments from 19 companies in 2025. Trend: 2023 $61 · 2024 $797 · 2025 $3,294
Food & beverage: $3,208Education: $86
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $712 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $337 |
| Janssen Biotech, Inc. | 15 | $319 |
| Madrigal Pharmaceuticals | 12 | $309 |
| Ipsen Biopharmaceuticals, Inc | 8 | $204 |
| Ardelyx, Inc. | 9 | $172 |
| GENZYME CORPORATION | 7 | $145 |
| Daiichi Sankyo Inc. | 4 | $115 |
| Regeneron Healthcare Solutions, Inc. | 5 | $115 |
Products named: XIFAXAN, TREMFYA, REZDIFFRA, ENTYVIO, DUPIXENT, RINVOQ, IQIRVO, LINZESS.
Industry payments across PA — which companies pay providers there.
